Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Sophia Genetics secures $234m in IPO

Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva


Jul 27, 2021

Solarisbank captures $224m at $1.6bn valuation

BBVA helped the banking software provider raise series D funding that supported its acquisition of digital banking services provider Contis.

Jul 27, 2021

Nium nets $200m in series D round

Visa invested in the digital payment platform developer at a valuation above $1bn, taking its overall funding to almost $300m.

Jul 27, 2021

Zilch fills series B up to $190m

Daily Mail and General Trust’s DMG Ventures unit was among the investors in the BNPL service provider’s $110m series B extension, which came after an $80m first close three months ago.

Jul 27, 2021

PropertyGuru to build $1.35bn reverse merger

The REA Group-backed real estate marketplace is set to carry out a reverse takeover at a $1.35bn valuation almost two years after it withdrew its attempt to float in Australia.

Jul 27, 2021

Outbrain counts up $160m in IPO

The Gruner + Jahr and Susquehanna International Group-backed content recommendation engine developer floated below its range but is slightly up from its IPO price.

Jul 27, 2021

ShareChat shoots to $145m

Mirae Asset-Naver Asia Growth Fund was among the investors as the social media and short-form video app developer expanded on a $502m round featuring Tencent and Snap.

Jul 27, 2021

Albotherm seeds a green future

Based on research at University of Bristol, Albotherm’s technology could revolutionise how greenhouses and buildings are cooled.

Jul 27, 2021

Vestwell executes $70m series C

Manulife, Nationwide, Allianz and Northwestern Mutual all took part in the enterprise savings software provider's latest round, which was co-led by Wells Fargo Strategic Capital.

Jul 27, 2021

Embark passes series B test with $75m

Dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.

Jul 27, 2021

Isolere Bio breaks the biomanufacturing bottleneck

Co-founder and CEO Kelli Luginbuhl talks to GUV about how the Duke spinout re-imagines the manufacturing of complex biologics.

Jul 27, 2021

Huang and Zeb to hang at GV

The Alphabet unit hired two partners for its enterprise and fintech team, three months after bringing Dan Lynch and EIR Mojca Skoberne on board.

Jul 27, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here